Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors
My Personal Therapeutics Ltd. (trading as
Vivan Therapeutics), a global leader in personalised cancer therapeutics and in-vivo high throughput drug screening, is pleased to announce the addition of
Lilly Wollman to its distinguished board of directors.
Lilly Wollman is a seasoned team-builder and entrepreneurial leader with a 20-year track record in finance and investing. Currently, she is pursuing an MPhil in Computational Biology from the University of Cambridge and is dedicated to a second career solving complex problems in human health through the application of data science and machine intelligence. She is currently a research intern in the CRUK Early Detection Programme, and at the Milner Therapeutics Institute.